A Phase II Study of Oxaliplatin Combined with 5-Fluorouracil and Leucovorin (Mayo Clinic Regimen) in 5-Fluorouracil Refractory Colorectal Cancer
Yee Zee Bae, Jae Hyuk Jung, Chang Hoon Moon, Seong Hyun Kim, Hyuk Chan Kwon, Jae Seok Kim, Hyo Jin Kim
Cancer Res Treat. 2002;34(3):218-222. Published online 2002 Jun 30 DOI: https://doi.org/10.4143/crt.2002.34.3.218
Citations to this article as recorded by 
Effect of Betulinic Acid on Anticancer Drug‐Resistant Colon Cancer Cells
Gwon‐Ryul Jung, Kyung‐Jong Kim, Cheol‐Hee Choi, Tae‐Beum Lee, Song Iy Han, Hyo‐Kyung Han, Sung‐Chul Lim
Basic & Clinical Pharmacology & Toxicology.2007; 101(4): 277. CrossRef
Oxaliplatin/5-FU without Leucovorin Chemotherapy in Metastatic Colorectal Cancer
Byoung Yong Shim, Kang Moon Lee, Hyeon-Min Cho, Hyun Jin Kim, Hong Joo Cho, Jinmo Yang, Jun-Gi Kim, Hoon-Kyo Kim
Cancer Research and Treatment.2005; 37(4): 212. CrossRef
The Efficacy of a Modified Chronomodulated Infusion of Oxaliplatin, 5-Fluorouracil and Leucovorin in Advanced Colorectal Cancer (Preliminary Data)
Ji Young Park, Si-Young Kim, Jae Jin Lee, Hwi Joong Yoon, Kyung Sam Cho
Cancer Research and Treatment.2004; 36(3): 199. CrossRef
Oxaliplatin with Biweekly, Low Dose Leucovorin and Bolus and Continuous Infusion 5-fluorouracil (Modified FOLFOX 4) as First-line Therapy for Patients with Metastatic Colorectal Cancer
Hyuk-Chan Kwon, Kyoung Tae Kim, Shin Ae Lee, Jong-Sung Park, Sung-Hyun Kim, Jae-Seok Kim, Hyo Jin Kim
Cancer Research and Treatment.2004; 36(2): 115. CrossRef